-
Following a thorough review of all strategic alternatives, ASLAN Pharmaceuticals Pte Ltd, the sole operating subsidiary of ASLAN Pharmaceuticals, has filed for voluntary liquidation
-
Quantuma (Singapore) Pte Limited International has been appointed as the official liquidator and will seek potential strategic alternatives for the Companys development programs, eblasakimab and farudodstat
SAN MATEO, Calif. and SINGAPORE, July 17, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (ASLAN or the Company), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that its Singapore-incorporated, sole operating subsidi…
Read the full article at: https://finance.yahoo.com/news/aslan-pharmaceuticals-announces-filed-voluntary-112500259.html